Federal grant · project grant (b)
Optical Tools to Study Purinergic Signaling - Project Summary/abstract Extracellular Atp and Adp Are Mediators of Purinergic Signaling in Cell-to-cell Communication in Virtually Every Tissue. Autocrine and Paracrine Purinergic Signaling Contributes to Normal Cellular Functions Such as Immune Cell Chemotaxis and Cell Volume Regulation, and Purinergic Signaling Also Contributes to Pathology in Injury, Infection, Sepsis, and a Number of Diseases. Notably, Extracellular Atp and Adp Mediate Purinergic Signaling Between Cells With Both Short-term and Long-term Effects. However, It Has Been a Challenge to Study the Cellular and Molecular Mechanisms by Which Atp and Adp Control Distinct Signaling Events Because Their Levels Are Spatially Heterogeneous and Purinergic Signaling Can Vary Significantly From Cell-to-cell. Clearly, Direct Measurements of Extracellular Nucleotides Are Needed, But Current Methods Are Not Well Adapted to Measuring Fluctuations in the Low Extracellular Nucleotide Concentrations Expected in Live Specimens. to Overcome This Barrier, We Will Use Protein Engineering to Develop High Affinity Cell-surface Sensors That Can Be Used to Resolve the Complex Spatial and Temporal Dynamics of Atp and Adp Release, Clearance, and Purinergic Receptor Activation. to Demonstrate the Application of Our Sensors and Also Guide Their Optimization, We Will Study Neuron-glia Purinergic Signaling in the Brain. in Particular, We Will Use Our Sensors to Learn How Metabolic State Affects the Function of Microglia, the Resident Immune Cells in the Brain, in Regulating the Regional Purinergic Dynamics That Impact Local Neuronal Activity. the Proposed Series of Multiplexed Imaging Studies That Pair Our Purinergic Sensors With Sensors of Downstream Signaling Should Directly Visualize Core Elements of Neuron-glia Purinergic Communication in an Integrated Manner. This Should Provide Valuable Insight Into Novel Mechanisms Responsible for the Coupling Between Brain Energy Metabolism and Excitability. Furthermore, the Genetically-encoded Tools Developed Through This Proposal Should Be Broadly Applicable to Deeper Study of Any Purinergic System.
Committed
$1.9 Million
Paid out
$1.7M
93%
Committed, not yet paid
$122.2K
7%
Loading…
Everything here is this single award's whole record — signed, amended, paid — not a fiscal-year slice. The by-year charts elsewhere split an award across the years it was committed; this page keeps it whole.
Committed is what the government has legally promised on this award so far. Contracts can also carry a ceiling — the maximum if every option is exercised. Unspent ceiling is headroom, not money owed.
The cash actually disbursed against this award. The gap from committed is the disbursement pipeline: promised, not yet cashed.
Each transaction is a signing event — an action that created or changed the award, dated the day it was signed — not a payment. Negative amounts are real: money de-committed at closeout or renegotiation.
One bar, the award’s whole arithmetic: paid out, then committed, not yet paid, then unspent ceiling.